[Update: 11:35 am Eastern, 12/10/09] Dendreon, the Seattle-based company developing a treatment to stimulate the immune system against prostate cancer, said today it has hired Hans Bishop as its chief operating officer. Bishop had previously been president of the specialty medicine division at Bayer Healthcare, where he oversaw cancer, neurology, and hematology products. He has a big job at Dendreon (NASDAQ: [[ticker:DNDN]]), where he’ll be responsible for the sales and marketing, as well as manufacturing, supply chain, quality, and facilities engineering involved with a first-of-its kind product in sipuleucel-T (Provenge). Bishop starts January 4.
[Update, 11:35 am Eastern] Bishop will start his job with a base salary of $450,000, and is eligible for performance bonuses worth as much as 45 percent of his base salary, Dendreon said today in a regulatory filing.
